More leading voices for #DayofImmunology 2026🧬
Makoto Miyara (Sorbonne University / Pitié-Salpêtrière) will join our #DOI2026 webinar, bringing clinical insight on #RegulatoryTcells in transplantation and autoimmunity.
📅 April 29 at 15:00
Registration 🔗👇
@yefis-immunology.bsky.social
20.02.2026 10:54
👍 4
🔁 5
💬 1
📌 0
The 3 hardest things to learn as a scientist:
1. Trust the data.. especially when it’s not what you expected,
2. Trust the data.. allowing it to change your direction,
3. Trust the data.. but not too much: test with new data at every turn.
19.02.2026 01:14
👍 55
🔁 15
💬 2
📌 1
Registration is now open and an all-in roster of immunologists anchor the premiere Dendritic cell meeting. www.dc2026sandiego.com/invited-spea... Sunny (blue state) San Diego. Sessions devoted to honoring 15 year anniversary of Nobel prize (Steinman) and translational advances…what is not to like.?
06.02.2026 05:05
👍 6
🔁 3
💬 0
📌 2
Registration for the PALS Summer School in Transcriptomics is Open 🧬 23-26 June 2026 www.trippus.net/summerschool...
Join us in this wonderful place 🇸🇪 to learn
Theory & Computation from Famous Scientists in the Field
w @remeseiro-lab.bsky.social
Support by @scilifelab.se & @kawresearch.bsky.social
28.01.2026 10:29
👍 9
🔁 7
💬 0
📌 2
Registration is OPEN for the cancer research community to join us for the #EACR2026 Congress! 🥳
Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 21 April.
2026.eacr.org
19.01.2026 09:01
👍 12
🔁 15
💬 0
📌 0
Why cancer can come back years later — and how to stop it
Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.
Understanding why cancers relapse - sometimes years or decades after successful treatment - is a major challenge in the cancer field
This perspective in Nature discusses several of the important recent advances and new studies in the field of tumor dormancy 🧪⚕️
www.nature.com/articles/d41...
07.01.2026 10:28
👍 38
🔁 23
💬 0
📌 1
Please share and distribute
ILC6 in Vancouver
Abstract submission and registration are open:
ilc6vancouver.com
#immunosky #ILC6vancouver #ILC6
Lots of presenter spots available
Secure your spot and discounted fees during early bird registration and come visit beautiful Vancouver.
15.01.2026 14:42
👍 3
🔁 6
💬 0
📌 1
@salva-iborra.bsky.social and Co in @jem.org elegantly sow that plasmacytoid DCs expand tissue-resident memory CD8+ T cell responses during viral reinfection
rupress.org/jem/article/...
13.01.2026 08:08
👍 11
🔁 6
💬 0
📌 0
Cell Symposia: Hallmarks of cancer
We're excited to host a distinguished lineup of speakers at @CellSymposia #CSHallmarks2026, including keynote speakers @johannajoyce.bsky.social & Faisal Mahmood @harvardmed.bsky.social. View the full speaker lineup: http://dlvr.it/TPbBqL
02.12.2025 18:01
👍 6
🔁 5
💬 0
📌 0
Tumour-reactive heterotypic CD8 T cell clusters from clinical samples
Tumour-reactive CD8+ T cells are enriched in functional clusters with tumour cells and/or antigen-presenting cells and can be isolated and expanded from clinical samples.
As the saying goes, one man’s trash is another man’s treasure: the flow-cytometry doublets that are routinely excluded from analysis are in fact a rich source of tumor-reactive T cells.
#immunology
#science
#tumor
#immunotherapy
buff.ly/pETJPEH
19.11.2025 19:32
👍 11
🔁 5
💬 2
📌 0
Our #SITC25 recap is out today!
Check out the standout presentations and insights from top institutions and speakers: bit.ly/3LLunuM.
19.11.2025 15:00
👍 4
🔁 3
💬 0
📌 0
How do world-leading scientists decide what makes it onto the EACR Congress stage?
In our latest podcast episode, Johanna Joyce, Joana Paredes and Mariangela Russo talk about the impact of the Congress and their experiences on the Scientific Programme Committee.
magazine.eacr.org/behind-the-s...
19.11.2025 09:01
👍 2
🔁 1
💬 0
📌 0
Haven't read this one yet, but looks like a fantastic resource for everyone working with complex #spectral #flowcytometry panels!
31.10.2025 14:22
👍 1
🔁 1
💬 0
📌 0
One of the highlights of the annual SSI meeting is the recognition of researchers who have made significant contributions in the immunology field in Scandinavia.
We want to extend our warmest congratulations to SWIMM member Chris Tibbitt @ki.se who was awarded the SSI Young Investigator Award 2025
31.10.2025 11:34
👍 4
🔁 3
💬 1
📌 0
CRATERs have been identified as sites of increased tumor antigen presentation where T cells can recognize and kill tumor cells bit.ly/3J8g42v @ayaludin.bsky.social
29.10.2025 16:45
👍 7
🔁 2
💬 0
📌 0
Our new publication in @cp-immunity.bsky.social: Tertiary lymphoid structures with signs of functional adaptive immune responses in a subset of human gliomas. Association with longer overall patient survival and more immune-permissive tumor microenvironment.
doi.org/10.1016/j.im...
22.10.2025 07:36
👍 13
🔁 11
💬 1
📌 1
📢📢FINAL CALL!! Closes tomorrow (Mon 20th Oct)
Want a cool, blue skies project, integrating machine learning with virology to develop the medicines 💊of the future?
Want to join a supportive team with an incredible culture?
Apply now! 🧬🔬🧪🦠👨🔬👩🔬
www.findaphd.com/phds/project...
19.10.2025 11:20
👍 2
🔁 1
💬 0
📌 0
Targeting and tracking mRNA lipid nanoparticles at the particle, transcript and protein level
Nature Biomedical Engineering - This Review explores strategies for targeting and tracking RNA-LNP drugs, monitoring their in vivo behaviour, enhancing tissue-specific delivery, and using synthetic...
Our new review in @natbiomedeng.nature.com is out!
RNA-loaded lipid nanoparticles (LNPs) have huge potential—but their strong liver and immune cell uptake has mostly confined them to vaccines and liver therapies. We explore how to move beyond those limits.
free to read 🔗 rdcu.be/eLxGs
17.10.2025 17:16
👍 34
🔁 11
💬 1
📌 0
Congrats! 🎉 Beautiful work and cover!
17.10.2025 08:15
👍 1
🔁 0
💬 0
📌 0
1/2 Sharing exciting news! ✨
Our recently published paper “Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity” has been selected for the cover of the October issue of Immunity!
@cp-immunity.bsky.social
14.10.2025 15:40
👍 10
🔁 2
💬 2
📌 0
